Overview

Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis

Status:
COMPLETED
Trial end date:
2024-12-20
Target enrollment:
Participant gender:
Summary
Several studies investigated the effectiveness of Gabapentin in Uremic Pruritus (UP). No previous studies investigated the use of fexofenadine in UP. The aim of this trial is to assess the safety and possible efficacy of fexofenadine in patients with UP.
Phase:
PHASE4
Details
Lead Sponsor:
Tanta University
Treatments:
fexofenadine
Gabapentin